Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL-DIABETES: Intensive vs Standard BP Control in Type 2 Diabetes
NCT04040634Completed
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Aug 2019
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in hypertension (HTN) (2 arms), sponsored by Hospital Israelita Albert Einstein. Primary endpoint: Major Adverse Cardiovascular Events at 48 months. Started Aug 2019; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04040634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040634.